Renflexis 100 MG vials
Ended Awarded
- Contract number
- SPE2DB25FD9Q1
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $46,605
Award facts
- Contract value 100% obligated
- $46,605.14 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $46,605.14 firm fixed price delivery order to AmerisourceBergen Drug Corp for the supply of Renflex 100 mg vials. This competitive delivery order, with no set-aside designation, is scheduled for completion by August 11, 2025, and will be performed at the awardee's facility in Conshohocken, Pennsylvania. Renflex (infliximab biosimilar) is a critical biologic pharmaceutical used to treat autoimmune conditions including rheumatoid arthritis, Crohn's disease, and ulcerative colitis, making this procurement essential for supporting military healthcare operations.
This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (SPE2DX) with DLA Troop Support Medical, a comprehensive pharmaceutical prime vendor agreement valued at $999,999,999.00 through December 2026. This prime IDC authorizes the contractor to supply a broad range of pharmaceutical products and medical supplies to support Department of Defense healthcare programs globally. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider headquartered in Pennsylvania, regularly fulfills federal medical procurement requirements across multiple therapeutic domains through competitively awarded contracts with the Defense Logistics Agency and supports military, veteran, and federal healthcare systems.
Quick answers
Who was awarded contract SPE2DB25FD9Q1?
SPE2DB25FD9Q1 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on August 8, 2025.
How much is contract SPE2DB25FD9Q1 worth?
The government has obligated $46,605 on SPE2DB25FD9Q1.
Is contract SPE2DB25FD9Q1 an order under another contract?
Yes. SPE2DB25FD9Q1 is a delivery order under SPE2DB20D1100, an indefinite delivery contract.
Was contract SPE2DB25FD9Q1 competed?
The extent of competition for SPE2DB25FD9Q1 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award